FENNEC PHARMACEUTICALS INC
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accounting Fees and Services
The following presents the aggregate fees for professional services and other services rendered by our independent auditors, Haskell & White LLP (PCAOB ID#200), in fiscal year 2023 and 2022:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Fiscal Year · · Fiscal Year | ||||||
| · 2023 · 2022 | ||||||
| Audit Fees(1) | $132,750 | $86,250 | ||||
| Audit-Related Fees(2) | | 14,000 | | 7,500 | ||
| Tax Fees(3) | | — | | — | ||
| All Other Fees(4) | | — | | — | ||
| Total | | $146,750 | | $93,750 | ||
| (1) | Audit Fees include fees for the standard audit work that needs to be performed each year in order to issue an opinion on the consolidated financial statements of the Company. It also includes fees for services that can only be provided by the Company’s auditor such as auditing of non-recurring transactions. |
| (2) | Audit-Related Fees include fees assurance and related services that are reasonably related to the performance of the audit or review and are traditionally performed by the independent accountant. |
| (3) | Tax Fees |
| (4) | All Other Fees include fees for products and services other than Audit Fees, Audit Related Fees and Tax Fees. |
The Audit Committee does not have formal pre-approval policies and procedures; however, prior to their engagement by us, the Audit Committee approved all of the services performed by Haskell & White LLP as required by SEC regulation.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.